MILD DISABLING ACUTE ISCHEMIC STROKE

Clinical trials for MILD DISABLING ACUTE ISCHEMIC STROKE explained in plain language.

Never miss a new study

Get alerted when new MILD DISABLING ACUTE ISCHEMIC STROKE trials appear

Sign up with your email to follow new studies for MILD DISABLING ACUTE ISCHEMIC STROKE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Brain-Shield drug added to Clot-Buster in major stroke recovery trial

Disease control Not yet recruiting

This study is testing if adding a brain-protecting drug (butylphthalide) to a standard clot-dissolving medicine (tenecteplase) helps people recover better after a mild but disabling stroke. Over 1,000 participants who have a stroke with mild symptoms but still have trouble with s…

Matched conditions: MILD DISABLING ACUTE ISCHEMIC STROKE

Phase: PHASE3 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control

Last updated Mar 12, 2026 13:51 UTC

MILD DISABLING ACUTE ISCHEMIC STROKE

Get alerted when new MILD DISABLING ACUTE ISCHEMIC STROKE trials appear

Brain-Shield drug added to Clot-Buster in major stroke recovery trial